S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
The single greatest medical breakthrough of all time? (Ad)
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
The single greatest medical breakthrough of all time? (Ad)
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
The single greatest medical breakthrough of all time? (Ad)
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
The single greatest medical breakthrough of all time? (Ad)
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
The single greatest medical breakthrough of all time? (Ad)
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
The single greatest medical breakthrough of all time? (Ad)
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
The single greatest medical breakthrough of all time? (Ad)
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
The single greatest medical breakthrough of all time? (Ad)
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
The single greatest medical breakthrough of all time? (Ad)
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
The single greatest medical breakthrough of all time? (Ad)
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
The single greatest medical breakthrough of all time? (Ad)
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
The single greatest medical breakthrough of all time? (Ad)
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
OTCMKTS:ATMS

Artemis Therapeutics (ATMS) Earnings Date, Estimates & Call Transcripts

$0.50
-1.39 (-73.65%)
(As of 05/25/2023)
Compare
Today's Range
$0.50
$0.50
50-Day Range
$0.10
$0.49
52-Week Range
$0.11
$5.00
Volume
1,000 shs
Average Volume
2,942 shs
Market Capitalization
$55.79 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Skip Charts & View Estimated and Actual Earnings Data

ATMS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ATMS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

ATMS Earnings Date and Information

Artemis Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 21st, 2023 based off prior year's report dates.

Artemis Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/21/2023
Estimated)
------- 
11/14/2022Q3 2022-($0.01)($0.01)($0.01)-$0.12 million
5/23/2022Q1 2022-($0.01)($0.01)($0.01)--
11/10/2021Q3 2021-($0.01)($0.01)($0.01)-$0.03 million
8/23/2021Q2 2021-($0.01)($0.01)($0.01)--
5/13/2021Q1 2021-($0.01)($0.01)($0.01)--
3/30/2021Q4 2020-($0.01)($0.01)($0.01)--












Artemis Therapeutics Earnings - Frequently Asked Questions

When is Artemis Therapeutics's earnings date?

Artemis Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 21st, 2023 based off last year's report dates. Learn more on ATMS's earnings history.

How much revenue does Artemis Therapeutics generate each year?

Artemis Therapeutics (OTCMKTS:ATMS) has a recorded annual revenue of $310,000.00.

How much profit does Artemis Therapeutics generate each year?

Artemis Therapeutics (OTCMKTS:ATMS) has a recorded net income of -$1.36 million. ATMS has generated $0.00 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (OTCMKTS:ATMS) was last updated on 8/14/2023 by MarketBeat.com Staff

My Account -